Dexmedetomidine /ml is one of 59 small molecule programs targeting Polyuria. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
224 competitors in Septic Shock
Dexmedetomidine /ml
Primaxin
Intropin
Zyvox
Doribax
Spravato
Tygacil
Lipitor
Avastin
Cubicin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details